Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Noble Acquires Property with Significant Uranium, Rare Earth, Phosphorus & Silver Mineralization (click to learn more) V.AFM: Record Fy2024 & Q4 ‘24 Tin Production Fy2025 Production Guidance Exploration Success (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Nutriband Equity Warrant Exp 30th Sep 2026 NTRBW

Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:NTRBW)

Nutriband Issues Letter to Shareholders

GlobeNewswire December 31, 2024

Nutriband Extends Chinese Patent to Macao for its AVERSA(TM) Abuse Deterrent Transdermal Technology

GlobeNewswire December 27, 2024

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

GlobeNewswire December 4, 2024

Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th

GlobeNewswire December 4, 2024

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa(TM) Abuse Deterrent Transdermal Technology

GlobeNewswire November 27, 2024

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

Accesswire October 31, 2024

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

Accesswire October 17, 2024

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

Accesswire October 2, 2024

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

Accesswire September 24, 2024
View More News ››

Opinion & Analysis (NDAQ:NTRBW)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:NTRBW)

NTRBW: Nutriband&#8217;s Abuse-Deterrent Transdermal Technol

http://beyondspx.com/2024/08/02/ntrbw-nutribands-abuse-deterrent-transdermal-technology-offers-significant-upside-potential/
MikeTester - August 3, 2024
View more Bullboard ››

Africa Oil Corp.

Africa Oil Corp.

Africa Oil Corp. is a Canadian oil and gas company with producing and development assets in deepwater Nigeria, an interest in ...
View More »